Publikationen

Radiology. 2015 Mar 4. doi: 10.1148/radiol.15141905

Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.

Pinker K¹, Baltzer P², Bogner W³, Leithner D⁴, Trattnig S⁵, Zaric O⁶, Dubsky P⁷, Bago-Horvath Z⁸, Rudas M⁹, Gruber S¹⁰, Weber M¹¹, Helbich TH¹²

Author information

¹From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
²From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
³From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
⁴From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
⁵From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
⁶From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
⁷From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
⁸From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
⁹From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
¹⁰From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
¹¹From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
¹²From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging (K.P., P.B., D.L., M.W., T.H.H.), Department of Biomedical Imaging and Image-guided Therapy, MR Centre of Excellence (W.B., S.T., O.Z., S.G.), Department of Surgery (P.D.), and Department of Pathology (Z.B.H., M.R.), Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

Abstract

Purpose To ascertain whether multiparametric magnetic resonance (MR) imaging of the breast in combination with dynamic contrast material-enhanced (DCE) imaging and diffusion-weighted imaging (DWI) at 7 T is feasible and improves diagnostic accuracy. Materials and Methods From December 2011 to December 2013, 40 patients with suspicious breast lesions were included in this institutional review board-approved prospective study. Before bilateral multiparametric MR imaging of the breast at 7 T, all patients gave written informed consent. Lesions were classified according to Breast Imaging Reporting and Data System (BI-RADS) and assessed for apparent diffusion coefficient (ADC) values by two readers independently. For combined analysis of DCE MR imaging and DWI, the BI-RADS-adapted reading algorithm, which adapted ADC thresholds to the BI-RADS assessment category, was used. Diagnostic values of multiparametric, DCE MR imaging, and DWI were calculated. Receiver operating characteristic curve analysis was performed. Image quality and interreader agreement were assessed. Histopathologic results were used as the highest standard. Results There were 29 malignant and 17 benign lesions (range, 6-95 mm; mean, 23.3 mm). Multiparametric MR imaging yielded a sensitivity of 100% (29 of 29 lesions), a specificity of 88.2% (16 of 18 lesions), and an area under the curve of 0.941, which was greater than for DCE MR imaging (P = .003), which had a sensitivity of 100% (29 of 29 lesions), a specificity of 53.2% (nine of 17 lesions), and an area under the curve of 0.765. DWI had a sensitivity of 93.1% (27 of 29 lesions), a specificity of 88.2% (15 of 17 lesions), and an area under the curve of 0.907. Multiparametric MR imaging at 7 T of the breast eliminated all false-negative findings and reduced false-positive findings, from eight false-positive findings with DCE MR imaging to two false-positive findings. Thus, if used clinically, 7-T multiparametric MR imaging may have potentially obviated unnecessary breast biopsies in six of eight lesions (P = .031). Multiparametric MR imaging demonstrated either excellent or good image quality and interreader agreement (κ = 0.89-1.00). Conclusion The clinical use of 7-T multiparametric MR imaging is feasible, provides good or excellent image quality, and has the potential to improve diagnostic accuracy. (©) RSNA, 2015 Online supplemental material is available for this article.

Publikations ID: 25751227
Quelle: öffnen

Drucken

Schnellinfo

-- Initiative Krebsforschung / Krebsforschungslauf

-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt

Zuklappen

Ausklappen

Schnellinfo

Featured